Furosemide and Ethacrynic Acid in Renal Insufficiency (Q39995249)

16 September 2017

1 reference

title

Furosemide and Ethacrynic Acid in Renal Insufficiency (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

20 March 2023

1 reference

N. W. Levin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4923428

20 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4923428

20 March 2023

publication date

1 January 1971

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:S0025712516325469?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

https://api.elsevier.com/content/article/PII:S0025712516325469?httpAccept=text/plain

20 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Medical Clinics of North America

20 March 2023

published in

1 reference

16 September 2017

volume

55

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

107-119

1 reference

Use of diuretic agents during oliguria after renal transplantation

16 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Use of Ethacrynic Acid in Mannitol-Resistant Oliguric Renal Failure

20 March 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

EXPERIENCES WITH FUROSEMIDE IN RENAL DISEASE

20 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Redistribution of Renal Blood Flow Produced by Furosemide and Ethacrynic Acid

20 March 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ethacrynic acid and furosemide: Renal pharmacology and clinical use

20 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Hazards of ethacrynic acid

20 March 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ethacrynic acid in acute renal failure

20 March 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Vasodilator properties of ethacrynic acid in the perfused dog kidney.

20 March 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ethacrynic acid: assessment of saluretic and diuretic potency in patients with severe chronic renal failure

20 March 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

The Short-Term Effect of Furosemide on Electrolyte and Water Excretion in Patients With Severe Renal Disease

20 March 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Deafness after ethacrynic acid

20 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Activation of the sympathico-adrenal system following the administration of diuretics--relationship to saluretic effect and glomerular filtration rate

20 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia

20 March 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

The renal regulation of sodium and potassium in patients with chronic renal failure (CRF) and the effect of diuretics on the excretion of these ions

20 March 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ethacrynic acid and furosemide.

20 March 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ethacrynic acid: two years' experience with a new diuretic

20 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

STUDIES ON ETHACRYNIC ACID IN PATIENTS WITH REFRACTORY EDEMA

20 March 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ototoxicity of Ethacrynic Acid and Aminoglycoside Antibiotics in Uremia

20 March 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Diuretic response to furosemide in the presence of renal insufficiency

20 March 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Diuretic properties of furosemide in renal disease

20 March 2023

38

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Deafness after ethacrynic acid

20 March 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Transient and permanent deafness following treatment with ethacrynic acid in renal failure

20 March 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Clinical use of furosemide

20 March 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

ON URIC ACID AND OTHER CLEARANCES AFTER INTRAVENOUS ADMINISTRATION OF FURSEMID IN MAN

20 March 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ethacrynic acid: Its usefulness and untoward effects

20 March 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Ototoxicity Induced by Furosemide

20 March 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Distribution and Urinary Excretion of Furosemide in the Rat

20 March 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Clinical use of high doses of furosemide (Lasix) in the treatment of resistant nephrotic edema

20 March 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Intravenously given ethacrynic acid and gastrointestinal bleeding. A finding resulting from comprehensive drug surveillance

20 March 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Furosemide. A clinical evaluation of its diuretic action

20 March 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Effects of certain inhibitors on renal excretion of salt and water

20 March 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

THE SITE OF ACTION OF FUROSEMIDE AND OTHER SULFONAMIDE DIURETICS IN THE DOG.

20 March 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Micropuncture experiments with saluretic sulfonamides

20 March 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Mechanism of the effects of furosemide on renin secretion in anesthetized dogs.

20 March 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

Micropuncture studies on energy metabolism and sodium transport in the mammalian nephron

20 March 2023

57

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

On the mode of action of diuretics II effects of ethacrynic acid on renal oxygen consumption and tubular sodium reabsorption in dogs

20 March 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32546-9

20 March 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4923428

20 March 2023

1 reference